期刊
PROCESS BIOCHEMISTRY
卷 76, 期 -, 页码 213-218出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.procbio.2018.10.004
关键词
Antihypertensive peptides; Antioxidant peptides; Angiotensin-converting enzyme; Spent brewer yeast; Hypertension; Food peptides
资金
- Agencia de Inovacao - ADI, Quadro de Referencia Estrategico Nacional (QREN, Portugal) through project ACTIPEP [QREN-ADI 11531]
- Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81901/2011]
- FCT by Fundacao para a Ciencia e Tecnologia, Portugal [UID/Multi/50016/2013]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/81901/2011] Funding Source: FCT
Numerous studies have investigated dietary approaches to prevent chronic lifestyle-related diseases, including hypertension. Spent brewer's yeast is the second largest byproduct originated by the brewing industry and it deserves considerable attention because of its high nutritional value, ca. 40% of its dry mass is rich in protein which can be hydrolyzed into biologically active peptides. To upgrade this byproduct, the aim of this study was initially in vitro assessment of biological properties, e.g. ACE inhibition and antioxidant activity, and then, the in vivo effect in short-term oral antihypertensive effect of hydrolyzed yeast fractions on a well characterized model to study hypertension - Spontaneously Hypertensive Rats (SHR). Here, it was demonstrated that the fraction with molecular weight below 3 kDa containing tri and tetra- peptides with hydrophobic amino acid residues - SPQW, PWW and RYW, causes the most noticeable decrease in systolic, diastolic and mean blood pressure of SHR and shows highest antioxidant effect. These properties highlight the potential use of yeast extract as nutraceutical or functional food ingredient for the management and treatment of hypertension with antioxidant effect.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据